MANF potentially could be worth billions. All the positive studies the last few years just increases the value. Amarantus should merge with Herantis as that would be be a powerhouse combo and lock up the market on NT factors. It's tough for either company to go it alone.

https://www.ncbi.nlm.nih.gov/pubmed/30032427